Comments
Loading...

NewAmsterdam Pharma Co Earnings Estimates

NAMSNASDAQ
Logo brought to you by Benzinga Data
$23.37
-0.21-0.89%
At close: -
$23.37
0.000.00%
After Hours: Mar 14, 4:00 PM EDT

NewAmsterdam Pharma Co Earnings Estimates, EPS & Revenue | NASDAQ:NAMS | Benzinga

NewAmsterdam Pharma Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 26
EPS
$-0.510
Quarterly Revenue
$8.63M
Annual Revenue
(as of Dec 31)
$45.56M

Analyze the earnings history of NewAmsterdam Pharma Co using advanced sorting and filters.

Data brought to you by Benzinga APIs

NewAmsterdam Pharma Co (NAMS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %

NewAmsterdam Pharma Co (NAMS) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is NewAmsterdam Pharma Co (NASDAQ:NAMS) reporting earnings?

A

NewAmsterdam Pharma Co (NAMS) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for NewAmsterdam Pharma Co (NASDAQ:NAMS)?

A

The Actual EPS was $-0.51, which missed the estimate of $0.00.

Q

What were NewAmsterdam Pharma Co’s (NASDAQ:NAMS) revenues?

A

The Actual Revenue was $8.6M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch